Disease | gout |
Phenotype | C0020502|hyperparathyroidism |
Sentences | 2 |
PubMedID- 22405053 | Introduction: increased frequencies of hyperuricemia and gout have been associated with primary hyperparathyroidism, and recent clinical trials of parathyroid hormone (pth) have reported hyperuricemic adverse events. |
PubMedID- 23413950 | Thiazide treatment has considerable metabolic side effects: unmasking normocalcaemic hyperparathyroidism, development of diabetes and gout, and erectile dysfunction contribute to a limited patient compliance (50–70%) and high dropout rate [12,16,33]. |
Page: 1